Vai al contenuto principale della pagina
| Autore: |
Moro Enrico
|
| Titolo: |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
|
| Pubblicazione: | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica: | 1 online resource (301 p.) |
| Soggetto topico: | Medicine |
| Soggetto non controllato: | A4GALT |
| alpha-galactosidase A | |
| animal models | |
| astrogliosis | |
| autophagy | |
| axon guidance | |
| biomarkers | |
| bone involvement | |
| cathepsin D | |
| chloroquine | |
| clathrin | |
| Dkk1 | |
| dried blood spot | |
| endocytic pathways | |
| endocytosis | |
| enzyme replacement therapy | |
| exosomes | |
| experimental therapies | |
| Fabry disease | |
| GAA biomarker | |
| Gaucher disease | |
| Gaucher Disease | |
| gene therapy | |
| GLA gene | |
| globotriaosyl-sphingosine (lysoGb3) | |
| globotriaosylceramide (Gb3) | |
| globotriaosylsphingosine | |
| glycogen | |
| hematopoietic stem cell transplantations | |
| Hurler syndrome | |
| IGF2R/M6P | |
| iPSC | |
| Krabbe disease | |
| lyso-Gb3 | |
| lysosomal diseases | |
| lysosomal storage disorder | |
| lysosomal storage disorders | |
| lysosomal targeting | |
| lysosomal α-glucosidase | |
| lysosome | |
| lysosomes | |
| MIP-1β | |
| mucolipidosis II | |
| mucopolysaccharidosis IIIB | |
| mucopolysaccharidosis type I | |
| muscle | |
| NAGLU | |
| neurodegenerative disease | |
| neuronal circuit | |
| neuronopathy | |
| newborn screening | |
| Osteoimmunology | |
| Osteopontin | |
| Parkinson disease | |
| pharmacological chaperone therapy | |
| pharmacological chaperones | |
| Pompe disease | |
| precision medicine | |
| psychosine | |
| quantitative proteomics | |
| RANK/RANKL | |
| rhGAA | |
| satellite cells | |
| second tier test | |
| sortilin | |
| substrate reduction therapy | |
| tandem mass spectrometry | |
| TGF-beta | |
| Twitcher mouse | |
| variant interpretation | |
| viral vectors | |
| visual cortex | |
| visual system | |
| Wnt/β-catenin | |
| Wnt3a | |
| α-galactosidase A | |
| Persona (resp. second.): | MoroEnrico |
| Sommario/riassunto: | Lysosomal storage disorders are a heterogenoeus group of rare genetic conditions affecting worldwide population and often exhibiting severe clinical manifestations. During the last two decades, the joined collaboration between scientists and clinicians has allowed to offer valuable therapeutic options to affected patients. Therefore, the tight connection between basic science and clinical medicine represents the gold standard approach to these disorders. In this context, the present book collects a piece of current scientific advances in the knowledge of disease pathogenesis and in the development of novel diagnostic and therapeutic strategies for some of these diseases. Altogether, these articles define and recapitulate which essential steps are required during the clinical management of a rare inherited disorder and describe forthcoming advances and a breakthrough in the field of lysosomal diseases. |
| Altri titoli varianti: | Lysosomal Storage Disorders |
| Titolo autorizzato: | Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910557545503321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |